2024 FLASCO Fall Session

Coming soon!

11:45AM-12:15PM
MDS Updates: New Drugs & Verona Study – Andrew Kuykendall, MD

1:15-1:45PM
Most Relevant Data in SCLC at ASCO 2024 – Alberto Chiappori, MD

2:15-3:15PM
Minimal Residual Disease Monitoring: Lung Cancer – Oleg Gligich, MD

11:00-11:20AM
Advances in Myeloma – Tiba Al Sagheer, PharmD, BCOP, BCACP

11:20-11:50AM
The Value of Onco-Pharmacy Prescence in ASCO – Stephen Grubbs, MD, FASCO

11:50AM- 12:15PM
Updates in Melanoma Pharmacotherapy – Katerine Dumais, PharmD, MPH, BCOP & Kayla Brice, PharmD, BCPS, BCOP

1:15-1:40PM
Impact of a Pharmacist-Driven Pharmacogenomic Monitoring Service – J. Kevin Hicks, PharmD, PhD, FCCP

2:20-2:40 PM
Lung Cancer Bispecific Review – Elizabeth Osmon, PharmD, BCPS, BCOP

11:00-11:50AM
Treatment Decisions: Research to Support Involvement of Patients and Families in Shared Decision-Making – Sarah Tinsley Vance, PhD, APRN, AOCN

1:15-1:45PM
The Impact of Penile Cancer – Gigi Jameel, MSN, MPH, ARNP & Tina Freamon, MSN, APRN

1:45-3:15 PM
Improving Patient Compliance with Vaginal Dilator Therapy After Radiation Therapy – Heather Augustyniak, DNP, APRN, FNP-C

1:45-3:15 PM
Elevating Oncology APP Practice: Key Findings from a Comprehensive APP Workforce Survey in a Community Health System – Heather Augustyniak, DNP, APRN, FNP-C & Meghan Hall, MSPAS, PA-C

1:45-3:15 PM
Establishing a HIPEC Program in a Community Hospital Setting: Early Quality Outcomes and the Role of Advanced Practice Providers – Meghan Hall, MSPAS, PA-C

11:00AM-12:15PM
Billing for Navigation Services: The Pro’s & Con’s – Kristina Rua, MSN, RN, OCN, ONN-CG

2:15-3:15PM
ASCO-ONS Antineoplastic Therapy Administration Safety Standards Updates – Mary MacKrell, RN, BSN, MSN, MEd, ONC, BMTCN & Juline George, PharmD, RPh

Coming soon!